{"id":"W1902187490","doi":"10.1016/s0022-3565(24)38776-2","title":"Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2","year":2001,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":460,"is_retracted":false,"has_abstract":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Etoricoxib; Valdecoxib; Cyclooxygenase; Pharmacology; Chemistry; Meloxicam; Celecoxib; Whole blood; Rofecoxib; Biochemistry; Medicine; Enzyme; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006517802,0.0006671695,0.001561593,0.0006585164,0.0002852744,0.0006295081,0.0006346796,0.0005772427,0.002289858],"category_scores_gemma":[0.0004724679,0.000303798,0.0005967498,0.0006669651,0.000421707,0.0009284415,0.0002312759,0.00180851,0.0006588133],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004457085,"about_ca_system_score_gemma":0.0008644233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000892139,"about_ca_topic_score_gemma":0.002596663,"domain_scores_codex":[0.9998254,0.00005295609,0.00002226958,0.00002169482,0.0000276298,0.00005002548],"domain_scores_gemma":[0.9997885,0.00003463503,0.00005017547,0.00002101211,0.00002119427,0.00008448136],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.2091482,0.03281058,0.005418776,0.001850518,0.001283368,0.0007654251,0.0002385418,0.006138565,0.3420697,0.001507986,0.0041134,0.3946549],"study_design_scores_gemma":[0.1327702,0.5852523,0.03965708,0.0001920161,0.002434286,0.003984866,0.0002747144,0.005924288,0.194992,0.0005474984,0.03374783,0.0002230014],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805046,0.01279966,0.0008677887,0.0003838431,0.0001326536,0.000392926,0.001099919,0.0001241958,0.003694346],"genre_scores_gemma":[0.9719118,0.01941763,0.002074377,0.0003038709,0.0002366542,0.0002697192,0.002494757,0.00003186105,0.003259319],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002289858,"threshold_uncertainty_score":0.007660329,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05945523468813936,"score_gpt":0.3922067227337764,"score_spread":0.332751488045637,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}